- Report
- April 2023
- 111 Pages
Global
From €4302EUR$4,750USD£3,712GBP
- Report
- August 2022
- 120 Pages
Global
From €4302EUR$4,750USD£3,712GBP
- Report
- January 2025
- 145 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- January 2025
- 75 Pages
Global
From €3500EUR$4,139USD£3,125GBP
- Report
- May 2024
- 120 Pages
Africa, Middle East
From €3125EUR$3,450USD£2,696GBP
- Report
- May 2024
- 87 Pages
Europe
From €3125EUR$3,450USD£2,696GBP
- Report
- May 2024
- 88 Pages
Asia Pacific
From €3125EUR$3,450USD£2,696GBP
- Report
- May 2024
- 84 Pages
North America
From €3125EUR$3,450USD£2,696GBP
- Report
- May 2024
- 75 Pages
From €3125EUR$3,450USD£2,696GBP
- Report
- November 2023
- 420 Pages
Global
From €4031EUR$4,450USD£3,478GBP
- Report
- November 2023
- 320 Pages
Global
From €4031EUR$4,450USD£3,478GBP
- Report
- January 2023
- 154 Pages
From €3125EUR$3,450USD£2,696GBP
- Report
- December 2023
- 255 Pages
Global
From €1132EUR$1,250USD£977GBP
€2264EUR$2,500USD£1,954GBP
- Report
- December 2023
- 80 Pages
France
From €1359EUR$1,500USD£1,172GBP
- Report
- December 2023
- 80 Pages
Germany
From €1359EUR$1,500USD£1,172GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1359EUR$1,500USD£1,172GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1359EUR$1,500USD£1,172GBP
- Report
- December 2023
- 80 Pages
United States
From €1359EUR$1,500USD£1,172GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1359EUR$1,500USD£1,172GBP
From €1359EUR$1,500USD£1,172GBP

The antimalarial market is a subset of the infectious diseases drugs market, which focuses on the treatment and prevention of malaria. Antimalarial drugs are used to treat and prevent the spread of the Plasmodium parasite, which is responsible for the disease. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Common antimalarial drugs include chloroquine, artemisinin, and mefloquine.
In addition to antimalarial drugs, the market also includes insecticides, insect repellents, and other preventive measures. These products are used to reduce the risk of infection by controlling the mosquito population, which is the primary vector for the Plasmodium parasite.
Notable companies in the antimalarial market include GlaxoSmithKline, Sanofi, Novartis, and Merck. These companies produce a variety of antimalarial drugs, insecticides, and other preventive measures. Show Less Read more